ALDH-2 inhibitors in the treatment of addiction
Details for Australian Patent Application No. 2007278877 (hide)
International Classifications
Event Publications
11 December 2008 PCT application entered the National Phase
PCT publication WO2008/014497 Priority application(s): WO2008/014497
26 March 2009 Alteration of Name
The name of the applicant has been altered to CV Therapeutics, Inc.
22 October 2009 Alteration of Name
The name of the applicant has been altered to Gilead Palo Alto, Inc.
7 January 2010 Assignment before Grant
Gilead Palo Alto, Inc. The application has been assigned to Gilead Palo Alto, Inc.; The Endowment for Research in Human Biology, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser